Page 184 – ORTHOWORLD

ATEC Takes Leap Forward in 2022

The company grew more than 44% in 2022 through its sole focus on spine surgery. ATEC expects to grow another...

Mar 02, 2023, Mike Evers

The company's product revenue declined in the low single digits in 2022 as it transforms its business model and contends...

Mar 02, 2023, Mike Evers

Xtant acquired the Coflex and Cofix product lines from Surgalign for a total consideration of $17 million....

Mar 01, 2023, Julie Vetalice

Exactech will include the Materialise Glenius solution in their portfolio to help patients with personalized implants in Europe and Australia....

Mar 01, 2023, Julie Vetalice

Funds will support work to meet regulatory requirements for the OsteoAdapt product in preparation for clinical studies....

Mar 01, 2023, Julie Vetalice

The product is a cancellous bone graft solution using Induce Biologics’ proprietary process, which unlocks the growth factors naturally found...

Mar 01, 2023, Julie Vetalice

Studies indicate that Moximed's MISHA Implantable Shock Absorber relieves pain and improves function in patients not ready for joint replacement....

Mar 01, 2023, Julie Vetalice

The company grew 18% in 2022, driven by accelerating demand momentum in its core SI-fusion business and increased surgeon engagement....

Mar 01, 2023, Mike Evers

Our chart of the month shows the projected top 10 largest players in spine after recent M&A deals in the...

Feb 28, 2023, Mike Evers

Hospital purchasing trends create opportunities for orthopedic companies to further invest in their relationships with customers....

Feb 28, 2023, Patrick McGuire